Similar articles

• [Estrogen substitution following the menopause and the risk of breast cancer; the importance of endogenous risk factors].

  Russchen CJ. Russchen CJ. Ned Tijdschr Geneeskd. 1992 Jul 11;136(28):1337-9. Ned Tijdschr Geneeskd. 1992. PMID: 1635595 Dutch. No abstract available.
• [Hormone replacement therapy and breast cancer--any news?].

  Holli K. Holli K. Duodecim. 1999;115(2):101-2. Duodecim. 1999. PMID: 11830839 Finnish. No abstract available.
• [Prevention and treatment of postmenopausal osteoporosis in women treated for cancer].

  Pratili MA, Gest-Laval C. Pratili MA, et al. Bull Cancer. 1992;79(7):651-7. Bull Cancer. 1992. PMID: 1467591 Review. French.
• [Which is the better choice, estrogen or SERMs in postmenopausal women?].

  Shintani M. Shintani M. Clin Calcium. 2004 Oct;14(10):105-10. Clin Calcium. 2004. PMID: 15577140 Review. Japanese.
• [Conventional hormonal replacement therapy in treatment of osteoporosis].

  Meczekalski B, Czyzyk A. Meczekalski B, et al. Pol Merkur Lekarski. 2009 Jul;27(157):72-6. Pol Merkur Lekarski. 2009. PMID: 19650436 Review. Polish.